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Abstract Wild-type full-length cDNA of von Willebrand factor (vWF) was expressed in CHO cells. Recombinant vWF (rvWF) was obtained and 
its molecular composition i vestigated by two-dimensional electrophoresis. Results of first dimension electrophoresis under non-reducing conditions 
showed that rvWF-dimer epresents a mixture of three different species. Second imension electrophoresis under reducing conditions revealed, that 
these protein species represent (i) homo-dimers ofeither two unprocessed ortwo fully processed, mature vWF polypeptides, and (ii) the hetero-dimer 
of unprocessed and mature rvWF monomers. Compared with vWF-dimers from human plasma, which contained predominantly proteolytically 
degraded polypeptides, recombinant vWF-dimers were shown to consist of non-proteolyzed subunits only. 
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1. Introduction 2. Materials and methods 
The adhesive protein von Willebrand factor exists in human 
plasma as a series of heterogeneous multimers ranging in size 
from about 450 kDa to more than 10,000 kDa [1-4]. The pre- 
cursor polypeptide produced in endothelial cells, pre-pro-vWF, 
consists of a 22-residue signal peptide, a 741-residue pro-pep- 
tide and the 2050-residue polypeptide found in mature plasma 
vWF. After removal of the signal peptide, the resulting pro- 
vWF subunits are engaged in a complex biosynthetic process 
thought o begin with the formation of a primary dimer, con- 
taining two pro-vWF subunits, through disulphide bond link- 
age. Then protomeric units of the multimeric series are assem- 
bled into higher order multimers by disulphide bonding of 
dimers, vWF pro-peptide is cleaved from multimeric vWF be- 
fore release from intracellular storage sites into circulation 
[1,3,5,6]. 
Electrophoretic analysis of plasma vWF dimer demonstrated 
a more complex pattern of repeating multimers, characterized 
by the presence of a more prominent band (primary dimer) 
surrounded by two (triplet structure) or more satellite bands 
[2,4,7]. Recently, two faster and two slower migrating satellite 
bands have been identified, running in a complex with the 
prominent band of the primary dimer of  plasma vWF [8,9]. 
More detailed investigations showed, that only the minority of 
plasma vWF primary dimer molecules consisted of two intact 
vWF-monomer polypeptide chains, whereas other protein spe- 
cies represented more or less proteolytically degraded vWF 
fragments [9]. A cleavage site between Tyr 842 and Met s43 in 
vWF-monomer polypeptide chain has been identified [10]. 
In this study, wild-type vWF full-length cDNA was ex- 
pressed in CHO cells. Recombinant vWF was obtained and its 
molecular structure investigated for the first time by two-di- 
mensional electrophoresis to detect the polypeptide composi- 
tion of recombinant von Willebrand factor dimers. 
*Corresponding author. Fax: (43) (2212) 2716. 
Abbreviations: Ag, antigen; CHO cells, Chinese hamster ovary cells; 
ELISA, enzyme-linked immunoabsorbent assay; PBS, phosphate-buff- 
ered saline; SDS, sodium dodecylsulfate; vWF, von Willebrand factor; 
rvWF, recombinant von WiUebrand factor. 
2.1. Materials 
Seakem Agarose HGT(P) and Gel Bond Film were purchased from 
FMC BioProducts. Acrylamide, N,N'-methylene-bis-acrylamide, so- 
dium dodecyl sulfate (SDS), glycine, ammonium persulfate and alkaline 
phosphatase coloration chemicals were from Bio-Rad Laboratories. 
Normal plasma was from Immuno AG, Austria. Rabbit anti-human 
vWF polyclonal antibody and alkaline phosphatase conjugated anti- 
rabbit polyclonal antibody were from Dakopatts. Enzyme-linked im- 
munoadsorbent assay for vWF was from Boehringer Mannheim. All 
other reagents were purchased from Sigma. 
2.2. Construction of the expression vector phAct-vWF 
The expression vector phAct-vWF originally represented a erivative 
of pSVfl [11]. Essentially, the SV40 promoter and SV40 16/19s intron 
of pSV,8 were substituted by the human fl-actin promoter and intron, 
and the bacterial f -galactosidase g ne was replaced by the human vWF 
cDNA [12]. Human vWF cDNA was kindly provided by Dr. J.A. van 
Mourik (Central Laboratory of the Netherlands Red Cross Blood 
Transfusion Service, Amsterdam). 
2.3. Transfection and cell culture 
20/./g phAct-vWF and 1 gg pSV-dhfr were transfected into dihydro- 
folate reductase deficient CHO-DXB 11 cells [13] according the calcium 
phosphate cotransfection technique by Graham and Van der Eb [14]. 
Six hours after transfection, the medium was aspirated and the cells 
were exposed to I ml 15% glycerol in phosphate-buffered saline (PBS) 
for 1 min. Cells were washed with PBS and culture medium (DMEM/ 
F12 1 : 1, containing 2 mmol/1 glutamine, 0.075% bicarbonate, 100 IU/ 
ml penicillin, 100 gg/ml streptomycin, 10% fetal calf serum, 10 gg/ml 
deoxyadenosine, 10gg/ml adenosine and 10 gg/ml thymidine) was 
added. 48 hours later, cells were split into selection medium and single 
colonies were isolated after 2 weeks. Positive clones were identified by 
testing the supernatants for rvWF with anti-vWF ELISA. For scale up, 
rvWF producing CHO clone #808-68 was grown in selection medium 
in roller bottles. 
2.4. SDS-agarose gel electrophoresis 
SDS-agarose gel electrophoresis was performed in a vertical electro- 
phoresis system using the buffer system and running conditions of 
Ruggeri and Zimmermann [2]. The separating gels (1.5% to 2% agarose 
concentration) and the stacking el (0.8% agarose), both 1.5 mm thick, 
were prepared as described by previously [2]. Prior electrophoresis 
protein samples were solubilized as described earlier [2]. 
2.5. Two-dimensional SDS electrophoresis 
Two-dimensional SDS electrophoresis was performed by a combina- 
tion of a high-resolution SDS-polyacrylamide/agarose gel for the first 
0014-5793/94/$7.00 © 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(94)00861-2 
346 
dimension and a SDS-polyacrylamide g l for the second dimension. 
SDS-polyacrylamide/agarose gels,containing 0.5% agarose and 3% 
acrylamide with 5% crosslinking, were prepared by melting 0.15 g 
agarose in 19 ml of distilled water. 3 ml acrylamide solution (30% 
acrylamide/h6% bis-acrylamide) and 7.5 ml of 1.5 mol/1 Tris-HCl 
buffer pH 8.8, containing 0.4% SDS were mixed and heated to 60°C. 
Agarose solution and acrylamide solution were mixed, and 15 /11 
TEMED and 0.5 ml ammonium persulfate (10 mg/ml) were added. The 
separation gel was poured between two prewarmed, inverted glass 
plates to form a 1.5 mm thick gel. Acrylamide polymerization was 
performed at 50°C for 30 min. Then agarose was solidified at room 
temperature. A 2.5% acrylamide stacking el was prepared as described 
by Laemmli [15]. Protein samples were denatured in 60 mmol/l Tris- 
HCI buffer pH 6.8, containing 2% SDS. Electrophoresis was performed 
at constant voltage of 30 V for 16 h. For resolution in the second 
dimension, a 5% acrylamide SDS-polyacrylamide gelwas prepared as 
described by Laemmli [15]. Individual gel lanes from the first dimension 
were excised and soaked for 30 min in 50 mmol/l Tris-HCl buffer pH 
8.8, containing 1% SDS and 3% 2-mercaptoethanol at 65°C. Gel strips 
were washed three times with 50 mmol/l Tris-HCl buffer pH 6.8, con- 
taining 0.1% SDS, and were then immobilized at the top of the second 
dimension gel. Electrophoresis was performed at constant voltage of 
200 V for 5 h. As reference proteins, prestained proteins with molecular 
weights of 205,000, 116,500, and 80,000 were used. 
2.6. Immunoblotting 
Polypeptides resolved by electrophoresis were transferred onto nitro- 
cellulose membranes in 25 mmol/l Tris, 192 mmol/l glycine, 20% (vol/ 
vol) methanol buffer [16]. Nitrocellulose membranes were blocked with 
20 mmol/l Tris-HCl, pH 8.3, containing 0.9% NaCI and reacted with 
1:1000 diluted rabbit anti-human vWF antibody for 16 h, followed by 
alkaline phosphatase conjugated goat anti-rabbit antibody. Coloration 
was done by incubation of the membranes in 100 ml substrate solution 
of 0.1 mol/l sodium bicarbonate buffer pH 9.8, containing 1mmogl 
MgCI:, 1 ml p-nitro blue tetrazolium chloride (30 g/1 in dimethylforma- 
mide), 1 ml 5-bromo-4-chloro-3-indoyl phosphate p-toluidine (15 g/1 in 
dimethylformamide). The reaction was stopped by rinsing the mem- 
branes in water. 
2. 7. vWF antigen determination 
The amount of vWF antigen in conditioned media of rvWF produc- 
ing permanent cell lines was determined using an enzyme-linked immu- 
noadsorbent assay. 
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Fig. 1. Analysis of (a) plasma derived and (b) recombinant vWF by 
non-reducing 1.5% SDS-agarose gel electrophoresis. 
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Fig. 2. Analysis of recombinant vWF by non-reducing 3% SDS- 
acrylamide/0.5% agarose gel electrophoresis. 
3. Results 
The wild-type full-length eDNA of von Willebrand factor, 
cloned in the expression vector phAct-vWF, was expressed 
under the control of the human fl-actin promotor in CHO cells. 
Expression levels of secreted rvWF reached about 5 mg/liter in 
the conditioned media. 
Multimer analysis was performed by SDS-agarose gel elec- 
trophoresis and SDS-polyacrylamide/agarose gel lectrophore- 
sis. Using 1.5% agarose, rvWF exhibited a multimeric pattern 
comparable with plasma vWF (Fig. 1). However, no separation 
into triplet structure of plasma vWF was obtained for rvWF. 
To get a high resolution picture of rvWF heterogeneity, SDS- 
3% acrylamide/0.5% agarose gel electrophoresis was carried out 
(Fig. 2). Results showed, that the primary dimer of rvWF can 
be separated into three protein bands containing approximately 
equal amounts. The first multimer (consisting of two dimers) 
was separated into even more bands. To analyse the molecular 
structure of the primary dimer of vWF, two-dimensional elec- 
trophoresis was carried out with non-reducing SDS-poly- 
acrylamide/agarose gel electrophoresis in the first dimension 
and reducing SDS-polyacrylamide g l electrophoresis in the 
second dimension. On both sides, additional sample wells were 
prepared for prestained molecular weight marker proteins and 
denatured-reduced vWF. Plasma vWF and rvWF were analy- 
sed simultaneously using identical conditions. Fig. 3 shows the 
two-dimensional electrophoresis of plasma vWF. The results 
showed, that in the first dimension, the primary dimer of 
plasma vWF was separated into several protein bands. These 
individual protein bands were numbered using a nomenclature 
similar to the terminology introduced by Dent et al. [9]. In 
agreement with results obtained by Dent et al. [9], the protein 
band identified as 1U was comprised exclusively of intact mon- 
omers o fvWF with a molecular weight of about 225 kDa. From 
the apparent molecular weight of about 450 kDa in the first 
dimension, protein IU contained two subunits linked by 
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disulphide bonds. All the other bands migrated faster than IU 
and contained proteolytically cleaved vWF fragments. How- 
ever, due to an apparent higher resolution of vWF in the SDS- 
polyacrylamide/agarose gel system used in this study, the broad 
protein band labeled as IP~ by Dent et al. [9] was shown to 
consist of at least four different species, labeled 1Pla, 1P~b, 1P~c 
and 1Pld in the present investigation. In the second dimension 
gel, vWF fragment compositions ofthe protein species 1Plb, 1P2 
and 1P3 were similar to those reported previously [9]. 
In contrast, two-dimensional electrophoresis of rvWF exhib- 
ited a quite different pattem (Fig. 4). High-resolution SDS- 
polyacrylamide/agarose g l electrophoresis howed three 
protein bands, labeled IUa, 1Ub and 1Uc. Second dimension 
electrophoresis showed, that species 1Ua contained exclusively 
mature vWF-monomer peptide chains. From the apparent mo- 
lecular weight of 450 kDa in the first dimension, 1Ua consisted 
of two identical vWF subunits, each of about 225 kDa. The 
position of protein 1Ua in the first and second dimension gel 
corresponded to the position of the protein species IU of 
plasma vWF (Fig. 3). Protein 1Ub apparently contained one 
mature vWF subunit and one pro-vWF subunit, whereas pro- 
tein 1U¢ apparently contained two pro-vWF subunits linked by 
disulphide bonds. 
4. Discussion 
Full-length cDNA of vWF has been cloned and rvWF has 
been expressed in heterologous cells for several years [6,17-25]. 
Expression of rvWF in heterologous cells, such as monkey 
kidney COS-1 [17-19,21,22] and CV-1 cells [23], baby hamster 
kidney cells [20], Chinese hamster ovary cells [20,22], human 
fibroblasts and mouse fibroblasts [20] resulted in the secretion 
of rvWF dimers and multimers, in a pattern apparently similar 
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Fig. 3. Two-dimensional analysis of plasma vWF. Plasma vWF was 
separated in the first dimension by non-reducing high resolution SDS- 
3% acrylamide/0.5% agarose gel electrophoresis. Individual gel lanes 
containing the primary dimer vWF-related proteins were cut out, incu- 
bated in reducing buffer, mounted on top of a 5% acrylamide gel, and 
electrophoresed in the second dimension (B). Simultaneously, dena- 
tured-reduced vWF (C) and prestained reference proteins (A) were 
analysed. 
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Fig. 4. Two-dimensional analysis of rvWF. rvWF was separated in the 
first dimension by non-reducing high resolution SDS-3% acrylamide/ 
0.5% agarose gel electrophoresis. Individual gel lanes containing the 
primary dimer vWF-related proteins were cut out, incubated in reduc- 
ing buffer, mounted on top of a 5% acrylamide gel, and electrophoresed 
in the second imension (B). Simultaneously, denatured-reduced rvWF 
(C) and prestained reference proteins (A) were analysed. 
to plasma vWF, when analysed in non-reducing low-resolution 
SDS-agarose gel electrophoresis systems. In contrast, SDS- 
PAGE at reducing conditions revealed that large proportions 
of secreted rvWF still contained the pro-polypeptide [6,17-23]. 
However, since this structural property is not reflected by con- 
ventional low-resolution SDS-agarose gel electrophoresis it has 
been ignored in interpretation ofconventional garose gel elec- 
trophoresis of recombinant vWF. More detailed structural 
analyses of rvWF molecules have not been reported. 
In this study, for the first time two-dimensional electrophore- 
sis has been used to analyse structural properties of rvWF and 
were compared to the plasma vWF structure. The investigation 
showed that rvWF differs significantly from plasma vWF. 
Plasma vWF at non-reducing conditions resulted at least seven 
polypeptides related to the primary dimer of vWF. In contrast, 
structural analysis of rvWF under non-reducing conditions re- 
suited in only three separate protein species related to the pri- 
mary dimer. Second dimension electrophoresis of rvWF under 
reducing conditions eparated the polypeptide compositions of 
each protein band related to the primary dimer: species IUa 
consisted exclusively of two mature vWF polypeptide chains 
linked by disulphide bonds, 1Ub represented a hybrid molecule 
of one mature vWF polypeptide chain and one pro-vWF pol- 
ypeptide chain linked by disulphide bonds, and IUc was the 
pro-vWF-dimer. In contrast, he primary dimer of plasma vWF 
consisted of predominantly proteolytically degraded polypep- 
tides. 
From previous experiments it has been established, that 
(a) vWF pro-polypeptide is not directly involved in dimeriza- 
tion of pro-vWF-monomers, and (b) the pro-peptide is an 
obligatory structural component for multimerizing vWF- 
dimers [6,18]. However, before release of vWF from endothelial 
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cells or intracellular storage sites, the pro-peptide is nearly 
completely cleaved from multimeric vWF [1]. Thus, the concen- 
tration of pro-vWF in the circulation is very low. In contrast, 
this study showed that all three possible combinations of pro- 
vWF polypeptide and mature vWF polypeptide, to form the 
primary dimer, were found in significant amounts. This phe- 
nomenon shows that, using current expression systems, the 
rates of vWF expression, multimerisation, secretion and pro- 
peptide processing may not be sufficiently balanced. 
The biotechnological production of recombinant proteins, 
such as vWF, represents an important step in large scale man- 
ufacturing of protein-based drugs. The results of this investiga- 
tion show, that rvWF obtained from transformed cells, in con- 
trast to plasma derived vWF, represents fully intact proteins 
rather then a mixture of different proteolytically degraded 
products. Thus, recombinant von Willebrand factor could 
prove to be a much better defined and purer product han vWF 
isolated from human plasma. 
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